PHARMACEUTICAL PERFORMANCE IN THE EVALUATION AND ADHERENCE TO PHARMACOLOGICAL TREATMENT OF TYPE 2 DIABETES MELLITUS. REMUNOM 2025, 9 (1), 1-13. https://doi.org/10.61164/rmnm.v9i1.3911.